128 related articles for article (PubMed ID: 32777211)
1. The role of PKC in CXCL8 and CXCL10 directed prostate, breast and leukemic cancer cell migration.
Alassaf E; Mueller A
Eur J Pharmacol; 2020 Nov; 886():173453. PubMed ID: 32777211
[TBL] [Abstract][Full Text] [Related]
2. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
Wu J; Liu S; Fan Z; Zhang L; Tian Y; Yang R
Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells.
Sun R; Gao P; Chen L; Ma D; Wang J; Oppenheim JJ; Zhang N
Cancer Res; 2005 Feb; 65(4):1433-41. PubMed ID: 15735031
[TBL] [Abstract][Full Text] [Related]
4. The role of PKC and PKD in CXCL12 directed prostate cancer migration.
Hamshaw I; Ajdarirad M; Mueller A
Biochem Biophys Res Commun; 2019 Oct; 519(1):86-92. PubMed ID: 31477269
[TBL] [Abstract][Full Text] [Related]
5. Cell migration towards CXCL12 in leukemic cells compared to breast cancer cells.
Mills SC; Goh PH; Kudatsih J; Ncube S; Gurung R; Maxwell W; Mueller A
Cell Signal; 2016 Apr; 28(4):316-24. PubMed ID: 26806619
[TBL] [Abstract][Full Text] [Related]
6. Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis.
Wu J; Zhang B; Wu M; Li H; Niu R; Ying G; Zhang N
Invest New Drugs; 2010 Jun; 28(3):268-75. PubMed ID: 19326049
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C inhibitors alter neurotensin receptor binding and function in prostate cancer PC3 cells.
Carraway RE; Hassan S; Dobner PR
Regul Pept; 2008 Apr; 147(1-3):96-109. PubMed ID: 18313772
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of PKCzeta expression inhibits chemotaxis signal transduction in human lung cancer cells.
Liu Y; Wang B; Wang J; Wan W; Sun R; Zhao Y; Zhang N
Lung Cancer; 2009 Feb; 63(2):210-8. PubMed ID: 18701187
[TBL] [Abstract][Full Text] [Related]
9. Protein Kinase C (PKC)ζ Pseudosubstrate Inhibitor Peptide Promiscuously Binds PKC Family Isoforms and Disrupts Conventional PKC Targeting and Translocation.
Bogard AS; Tavalin SJ
Mol Pharmacol; 2015 Oct; 88(4):728-35. PubMed ID: 26199377
[TBL] [Abstract][Full Text] [Related]
10. Fine-Tuning of GPCR-Chemokine Interactions. Design and Identification of Chemokine Analogues as Receptor Agonists, Biased Agonists, and Antagonists.
Navarro J
Biochemistry; 2019 Mar; 58(10):1432-1439. PubMed ID: 30726064
[TBL] [Abstract][Full Text] [Related]
11. The role of PKC and PKD in CXCL12 and CXCL13 directed malignant melanoma and acute monocytic leukemic cancer cell migration.
Hamshaw I; Ellahouny Y; Malusickis A; Newman L; Ortiz-Jacobs D; Mueller A
Cell Signal; 2024 Jan; 113():110966. PubMed ID: 37949381
[TBL] [Abstract][Full Text] [Related]
12. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
[TBL] [Abstract][Full Text] [Related]
13. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.
Cohen-Hillel E; Yron I; Meshel T; Soria G; Attal H; Ben-Baruch A
Cytokine; 2006 Jan; 33(1):1-16. PubMed ID: 16406804
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C is inhibited by bisphosphonates in prostate cancer PC-3 cells.
Tatsuda Y; Iguchi K; Usui S; Suzui M; Hirano K
Eur J Pharmacol; 2010 Feb; 627(1-3):348-53. PubMed ID: 19903468
[TBL] [Abstract][Full Text] [Related]
15. Cross-desensitization among CXCR1, CXCR2, and CCR5: role of protein kinase C-epsilon.
Nasser MW; Marjoram RJ; Brown SL; Richardson RM
J Immunol; 2005 Jun; 174(11):6927-33. PubMed ID: 15905535
[TBL] [Abstract][Full Text] [Related]
16. Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells.
Kruger JS; Reddy KB
Mol Cancer Res; 2003 Sep; 1(11):801-9. PubMed ID: 14517342
[TBL] [Abstract][Full Text] [Related]
17. Cbl and Akt regulate CXCL8-induced and CXCR1- and CXCR2-mediated chemotaxis.
Lane HC; Anand AR; Ganju RK
Int Immunol; 2006 Aug; 18(8):1315-25. PubMed ID: 16798838
[TBL] [Abstract][Full Text] [Related]
18. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12.
Inngjerdingen M; Rolstad B; Ryan JC
J Immunol; 2003 Sep; 171(6):2889-95. PubMed ID: 12960311
[TBL] [Abstract][Full Text] [Related]
19. Atypical protein kinase Cι as a human oncogene and therapeutic target.
Parker PJ; Justilien V; Riou P; Linch M; Fields AP
Biochem Pharmacol; 2014 Mar; 88(1):1-11. PubMed ID: 24231509
[TBL] [Abstract][Full Text] [Related]
20. Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer.
Datta D; Flaxenburg JA; Laxmanan S; Geehan C; Grimm M; Waaga-Gasser AM; Briscoe DM; Pal S
Cancer Res; 2006 Oct; 66(19):9509-18. PubMed ID: 17018607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
